Latest Funding Risk News

Pioneer Credit has reported a robust first half for FY26, more than doubling its net profit and upgrading its full-year earnings guidance to at least $20 million.

Commonwealth Bank of Australia’s latest Basel III Pillar 3 disclosures reveal steady capital adequacy ratios and proactive adaptation to evolving regulatory standards as of December 2025.

Lotus Resources has launched a A$81 million equity raising to support the ramp-up of its Kayelekera uranium mine to steady state production targeted in Q2 2026, while advancing development of its Letlhakane project.

Island Pharmaceuticals has raised $9 million to advance its antiviral drug Galidesivir through the FDA’s Animal Rule pathway, targeting inclusion in the US Strategic National Stockpile for biodefense viruses.

Bellavista Resources has announced a transformative acquisition of a 70% interest in the Pickle Crow Gold Project in Ontario, Canada, alongside a A$25 million equity raise to fund exploration and development.

Critica Limited has confirmed repeatable high-grade rare earth product quality at its Jupiter Project, delivering an 86% TREO concentrate and demonstrating gallium by-product potential. The company also secured an oversubscribed $8 million placement to fund pilot operations and a scoping study.

NuEnergy Gas Limited reported a cash outflow in Q4 2025 but secured a binding gas sales agreement and a strategic funding collaboration to advance its Indonesian coal bed methane projects.

Predictive Discovery Limited and Robex Resources have secured shareholder approval for their merger, aiming to create a leading mid-tier gold producer in West Africa with combined production exceeding 400,000 ounces annually by 2029.

Patriot Resources has secured a binding agreement to acquire the high-grade Tassa Silver-Gold deposit in Peru and completed an oversubscribed $4.25 million capital raising to fund exploration and acquisitions across its portfolio.

Neurizon Therapeutics has successfully raised $5.88 million through a well-supported entitlement offer, reinforcing investor confidence as it prepares to advance its lead drug candidate NUZ-001 in the HEALEY ALS Platform Trial.

Toubani Resources is poised to begin construction on its Kobada Gold Project in Mali after securing key environmental approvals and a substantial financing package. The company is advancing rapidly towards becoming a major gold producer in Africa.

Lunnon Metals has completed a detailed Feasibility Study for its Lady Herial gold deposit, outlining a robust, short-life open pit mine with strong pre-tax cash flows exceeding $40 million. The project is fully permitted and poised for imminent development.